Loading company…
Reunion develops medical hydrogel materials and devices for clinical applications.
Founded in Shanghai in 2018, Reunion develops medical hydrogels, including ready-to-use PEG hydrogel materials. Its clinical applications include protection during tumor radiotherapy, trauma repair, tumor embolization, and anti-tumor drugs. The company’s team includes members with experience at Fortune 500 companies, and its founder and chairman, Zhen Pan, previously worked as a technical expert for DuPont. In February 2026, it raised approximately CNY 100 million in Series C funding co-led by Fudan Innovation Centre and Qiming Venture Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in